Foundation Medicine, AstraZeneca in cancer deal

Foundation Medicine Inc. (Cambridge, Mass.) and AstraZeneca plc (LSE:AZN; NYSE:AZN) partnered to identify mutations in cancer-related tumor genes that may predict a person's response or resistance to ...